XML 48 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Business Segment Information (Tables)
 6 Months Ended
Jun. 30, 2014
Business Segment Information  
Schedule of operating results by business segment

The following tables summarize, for the periods indicated, operating results by business segment (in thousands):

 
   Commercial   Public
Sector		   Specialty
Solutions		   Pharmacy
Management		   Corporate
and
Elimination		   Consolidated  

Three Months Ended June 30, 2013

                                      

Managed care and other revenue

   $ 199,538   $ 414,859   $ 92,715   $ 55,829   $ (16,221 ) $ 746,720  

PBM and dispensing revenue

     —     —     —     96,028     —     96,028  

Cost of care

     (123,227 )   (357,402 )   (58,742 )   (14,480 )   16,221     (537,630 )

Cost of goods sold

     —     —     —     (90,175 )   —     (90,175 )

Direct service costs and other

     (41,399 )   (28,934 )   (13,863 )   (31,374 )   (28,927 )   (144,497 )

Stock compensation expense(1)

     133     267     457     380     3,365     4,602  
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Segment profit (loss)

   $ 35,045   $ 28,790   $ 20,567   $ 16,208   $ (25,562 ) $ 75,048  
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
                           


 

 
   Commercial   Public
Sector		   Specialty
Solutions		   Pharmacy
Management		   Corporate
and
Elimination		   Consolidated  

Three Months Ended June 30, 2014

                                      

Managed care and other revenue

   $ 198,025   $ 319,954   $ 119,326   $ 44,969   $ —   $ 682,274  

PBM and dispensing revenue

     —     —     —     209,265     (3,525 )   205,740  

Cost of care

     (116,852 )   (275,108 )   (89,753 )   96     —     (481,617 )

Cost of goods sold

     —     —     —     (196,080 )   3,514     (192,566 )

Direct service costs and other

     (42,530 )   (45,391 )   (17,897 )   (41,605 )   (31,611 )   (179,034 )

Stock compensation expense(1)

     157     230     354     5,556     3,253     9,550  

Less: non-controlling interest segment profit (loss)(2)

     —     (648 )   —     —     —     (648 )
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Segment profit (loss)

   $ 38,800   $ 333   $ 12,030   $ 22,201   $ (28,369 ) $ 44,995  
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
                           


 

 
   Commercial   Public
Sector		   Specialty
Solutions		   Pharmacy
Management		   Corporate
and
Elimination		   Consolidated  

Six Months Ended June 30, 2013

                                      

Managed care and other revenue

   $ 387,375   $ 821,479   $ 182,993   $ 108,928   $ (31,466 ) $ 1,469,309  

PBM and dispensing revenue

     —     —     —     195,200     —     195,200  

Cost of care

     (236,498 )   (712,781 )   (116,809 )   (28,035 )   31,466     (1,062,657 )

Cost of goods sold

     —     —     —     (183,687 )   —     (183,687 )

Direct service costs and other

     (82,791 )   (54,577 )   (27,234 )   (60,935 )   (58,587 )   (284,124 )

Stock compensation expense(1)

     266     574     891     700     7,809     10,240  
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Segment profit (loss)

   $ 68,352   $ 54,695   $ 39,841   $ 32,171   $ (50,778 ) $ 144,281  
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
                           


 

 
   Commercial   Public
Sector		   Specialty
Solutions		   Pharmacy
Management		   Corporate
and
Elimination		   Consolidated  

Six Months Ended June 30, 2014

                                      

Managed care and other revenue

   $ 386,916   $ 817,897   $ 224,760   $ 100,347   $ (18,055 ) $ 1,511,865  

PBM and dispensing revenue

     —     —     —     348,889     (6,265 )   342,624  

Cost of care

     (228,054 )   (697,626 )   (163,405 )   (16,295 )   18,055     (1,087,325 )

Cost of goods sold

     —     —     —     (324,111 )   6,247     (317,864 )

Direct service costs and other

     (82,806 )   (88,349 )   (33,038 )   (77,156 )   (62,407 )   (343,756 )

Stock compensation expense(1)

     312     504     768     5,859     6,579     14,022  

Less: non-controlling interest segment profit (loss)(2)

     —     (1,978 )   —     —     —     (1,978 )
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Segment profit (loss)

   $ 76,368   $ 34,404   $ 29,085   $ 37,533   $ (55,846 ) $ 121,544  
                           
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
                           
(1)
Stock compensation expense is included in direct service costs and other operating expenses, however this amount is excluded from the computation of Segment Profit since it is managed on a consolidated basis.

(2)
The non-controlling portion of AlphaCare's segment profit (loss) is excluded from the computation of Segment Profit.

       
Schedule of reconciliation of Segment Profit to income before income taxes

The following table reconciles Segment Profit to income before income taxes (in thousands):

 
   Three Months Ended
June 30,		   Six Months Ended
June 30,		  
 
   2013   2014   2013   2014  

Segment profit

   $ 75,048   $ 44,995   $ 144,281   $ 121,544  

Stock compensation expense

     (4,602 )   (9,550 )   (10,240 )   (14,022 )

Non-controlling interest segment profit (loss)

     —     (648 )   —     (1,978 )

Depreciation and amortization

     (16,946 )   (22,480 )   (33,116 )   (42,709 )

Interest expense

     (792 )   (2,004 )   (1,402 )   (2,840 )

Interest income

     358     275     711     586  
                   
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​

Income before income taxes

   $ 53,066   $ 10,588   $ 100,234   $ 60,581  
                   
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​ ​
                   

       
Summary of assets used in operations of segment

The following tables summarize those assets that are used in the operations of each segment. The remainder of the Company's assets cannot be specifically identified by segment (in thousands):

 
   Commercial   Public
Sector		   Specialty
Solutions		   Pharmacy
Management		   Corporate
and
Elimination		   Consolidated  

Year Ended December 31, 2013

                                      

Restricted cash

   $ 25,107   $ 196,651   $ —   $ —   $ 14,938   $ 236,696  

Net accounts receivable

     50,407     62,977     7,368     115,527     1,906     238,185  

Investments

     16,491     92,966     —     —     98,856     208,313  

Pharmaceutical inventory

     —     —     —     49,609     —     49,609  

Goodwill

     120,485     20,882     104,549     242,290     —     488,206  

Other intangible assets, net

     3,513     4,590     3,686     57,905     —     69,694  


 

 
   Commercial   Public
Sector		   Specialty
Solutions		   Pharmacy
Management		   Corporate
and
Elimination		   Consolidated  

Six Months Ended June 30, 2014

                                      

Restricted cash

   $ 11,630   $ 148,316   $ —   $ —   $ 7,367   $ 167,313  

Net accounts receivable

     52,625     71,993     9,839     160,916     6,496     301,869  

Investments

     35,838     129,575     —     —     5,942     171,355  

Pharmaceutical inventory

     —     —     —     44,277     —     44,277  

Goodwill

     120,485     20,879     104,549     311,512     —     557,425  

Other intangible assets, net

     2,772     6,831     3,012     134,370     —     146,985